TIGIT and COVID-19: Furthermore, an increased fraction of cells expressing LAG3, as well as a decreased proportion of cells marked by the expression of TIGIT, was observed in the CD4+ T cell population of patients who recovered from COVID-19 as compared with patients with COVID-19 and with healthy controls (Figure 1, G and H), suggesting the persistence of an abnormal exhaustion profile even after symptom remission.